We are live on ! Find out more
SSWM

Smith Salley Wealth Management Portfolio holdings

AUM $2.3B
1-Year Est. Return 38.65%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+38.65%
3 Year Est. Return
+105.94%
5 Year Est. Return
+133.49%
10 Year Est. Return
+415.99%
AUM
$497M
AUM Growth
+$9.63M
Cap. Flow
+$1.87M
Cap. Flow %
0.38%
Top 10 Hldgs %
24.08%
Holding
178
New
5
Increased
63
Reduced
86
Closed
7

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$4.24M
2
AME icon
Ametek
AME
+$4.14M
3
SNA icon
Snap-on
SNA
+$3.94M
4
FBNC icon
First Bancorp
FBNC
+$3.34M
5
SKT icon
Tanger
SKT
+$2.41M

Sector Composition

Rank Sector Weight
1 Financials 17.79%
2 Healthcare 15.49%
3 Technology 14.19%
4 Industrials 12.26%
5 Consumer Discretionary 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$190B
$6.21M 1.25%
53,741
+238
+0.4% +$27.3K
V icon
27
Visa
V
$690B
$6.08M 1.22%
64,827
+835
+1% +$77.5K
ABT icon
28
Abbott
ABT
$182B
$6.03M 1.21%
124,034
+1,421
+1% +$64.3K
MRK icon
29
Merck
MRK
$316B
$5.91M 1.19%
96,570
-602
-0.6% -$36.6K
JCI icon
30
Johnson Controls International
JCI
$93.1B
$5.86M 1.18%
135,027
+4,297
+3% +$180K
UNP icon
31
Union Pacific
UNP
$176B
$5.8M 1.17%
53,256
+910
+2% +$99.2K
AIG icon
32
American International
AIG
$42.1B
$5.79M 1.16%
92,545
-71,436
-44% -$4.44M
BN icon
33
Brookfield
BN
$109B
$5.57M 1.12%
398,137
+17,148
+5% +$231K
AMZN icon
34
Amazon
AMZN
$2.99T
$5.53M 1.11%
114,160
+360
+0.3% +$17.2K
DD
35
DELISTED
Du Pont De Nemours E I
DD
$5.36M 1.08%
66,421
-322
-0.5% -$25.7K
HON icon
36
Honeywell
HON
$78.9B
$5.26M 1.06%
43,660
+193
+0.4% +$22.8K
SLB icon
37
SLB Ltd
SLB
$75.4B
$4.9M 0.99%
74,474
+124
+0.2% +$8.89K
TMO icon
38
Thermo Fisher Scientific
TMO
$209B
$4.79M 0.96%
27,449
+25,270
+1,160% +$4.24M
DIS icon
39
Walt Disney
DIS
$170B
$4.63M 0.93%
43,595
-18,433
-30% -$2.02M
DD icon
40
DuPont de Nemours
DD
$19.3B
$4.59M 0.92%
28,749
+301
+1% +$47.8K
AME icon
41
Ametek
AME
$58.2B
$4.49M 0.9%
74,162
+70,275
+1,808% +$4.14M
CVS icon
42
CVS Health
CVS
$133B
$4.47M 0.9%
55,592
-409
-0.7% -$32.3K
EFA icon
43
iShares MSCI EAFE ETF
EFA
$79.3B
$4.44M 0.89%
68,047
+363
+0.5% +$23.5K
AGG icon
44
iShares Core US Aggregate Bond ETF
AGG
$138B
$4.31M 0.87%
39,327
+2,625
+7% +$287K
BKNG icon
45
Booking.com
BKNG
$151B
$4.17M 0.84%
55,700
-31,350
-36% -$2.3M
SKT icon
46
Tanger
SKT
$4.68B
$3.93M 0.79%
151,302
+84,775
+127% +$2.41M
EOG icon
47
EOG Resources
EOG
$76.4B
$3.91M 0.79%
43,161
-350
-0.8% -$32.2K
PFE icon
48
Pfizer
PFE
$145B
$3.85M 0.77%
120,652
+1,603
+1% +$50.6K
EQT icon
49
EQT Corp
EQT
$33B
$3.84M 0.77%
120,524
-174
-0.1% -$5.51K
SNA icon
50
Snap-on
SNA
$21.6B
$3.8M 0.76%
+24,054
New +$3.94M

Similar funds

Smith Salley Wealth Management's Q2 2017 Portfolio in Review

As of Q2 2017, Smith Salley Wealth Management held 178 positions worth $497M, up 2% from $488M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Smith Salley Wealth Management's Q2 2017 filing shows 5 new, 63 increased, 86 reduced and 7 closed positions. Its largest new stake was Snap-on: 24,054 shares worth $3.8M. The largest sale was Express Scripts Holding Company, an estimated $4.94M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Smith Salley Wealth Management's largest Q2 2017 buy was Snap-on: 24,054 shares worth $3.8M.
  • Smith Salley Wealth Management added most to Thermo Fisher Scientific in Q2 2017, an estimated $4.24M increase.
  • Smith Salley Wealth Management's biggest Q2 2017 reduction was American International, cutting an estimated $4.44M.
  • Smith Salley Wealth Management fully exited Express Scripts Holding Company in Q2 2017, selling an estimated $4.94M.
  • Smith Salley Wealth Management's ten largest holdings make up 24% of its $497M portfolio in Q2 2017.
  • Smith Salley Wealth Management opened 5 new positions and closed 7 in Q2 2017.
  • Smith Salley Wealth Management's portfolio value rose 2% quarter-over-quarter to $497M.

Based on Smith Salley Wealth Management's 13F filing for Q2 2017, filed 25 Jul 2017.